提高糖尿病患者种植成功率的研究进展

摘要/Abstract

摘要： 种植是一项广泛应用且安全可靠的缺牙修复方式，但是局部和系统的危险因素会降低其成功率。糖尿病作为一种慢性疾病，被认为是牙种植手术的绝对或者相对禁忌证。众多研究表明糖尿病患者种植体骨结合能力较差，成功率远远低于非糖尿病患者。随着我国生活水平的提高，糖尿病患者数量逐年增多，如何提高糖尿病患者种植的成功率也逐渐成为种植研究的热点和重点。该文从不同的方面阐述提高糖尿病患者种植成功率的方法，为糖尿病患者获得更高的临床种植成功率提供研究思路。

关键词: 糖尿病, 种植体, 成功率

Abstract: Dental implant is a widely used, safe and reliable way to repair losing teeth, but local and systemic risk factors may reduce its success rate. As a chronic disease, diabetes is considered to be an absolute or relative contraindication to dental implant surgery. Numerous studies have shown that patients with diabetes have poor implant osseointegration ability, and the success rate is much lower than that of non-diabetics. With the improvement of living standards in China, the number of diabetic patients is increasing year by year. How to improve the success rate of diabetes patients has gradually become a hotspot and focus of research. Therefore, this article will elaborate on ways to improve the success rate of diabetes patients from different aspects, and provide research ideas for diabetes patients to obtain higher clinical success rate.

Key words: diabetes, implant, osseointegration

中图分类号:

R783.5

吴旋张东姣马晓妮徐欣. 提高糖尿病患者种植成功率的研究进展[J]. , 2019, 39(5): 459-463.

参考文献

References:
[1]. Cho, N.H., et al., IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research & Clinical Practice, 2018. 138: p. 271.
[2]. 廖涌, 中国糖尿病的流行病学现状及展望. 重庆医科大学学报, 2015(7): 第1042-1045页.
[3]. Klokkevold, P.R., Cone Beam Computed Tomography for the Dental Implant Patient. J Calif Dent Assoc, 2015. 43(9): p. 521-30.
[4]. Moraschini, V., et al., Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg, 2015. 44(3): p. 377-88.
[5]. Giglio, M.J., et al., Histomorphometric study of bone healing around laminar implants in experimental diabetes. Implant Dentistry, 2000. 9(2): p. 143-149.
[6]. Oates, T.W., et al., A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res, 2013. 24(2): p. 117-27.
[7]. Aguilar-Salvatierra, A., et al., Peri-implant evaluation of immediately loaded implants placed in esthetic zone in patients with diabetes mellitus type 2: a two-year study. Clin Oral Implants Res, 2016. 27(2): p. 156-61.
[8]. Jadhav, R., et al., Dental implant in diabetic patients: Statement of facts. 2015. 6(2): p. 47.
[9]. Naujokat, H., B. Kunzendorf and J. Wiltfang, Dental implants and diabetes mellitus-a systematic review. Int J Implant Dent, 2016. 2(1): p. 5.
[10]. Kohnert, K.D., et al., Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract, 2007. 77(3): p. 420-426.
[11]. 周健等, 应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度. 中华内分泌代谢杂志, 2006. 22(3): 第286-288页.
[12]. 刘乃彬, 血糖波动对2型糖尿病大鼠种植体骨结合影响的实验研究, 2013, 第四军医大学.
[13]. Hegab, A.F., Dental Infection and Diabetes: The Cycle. 2015. 3.
[14]. Keenan, J.R. and A. Veitz-Keenan, Antibiotic prophylaxis for dental implant placement? Evid Based Dent, 2015. 16(2): p. 52-3.
[15]. Escalante, M.G., et al., Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation. J Periodontol, 2015. 86(11): p. 1190-200.
[16]. Arduino, P.G., et al., Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: A two-centre randomised controlled trial. Eur J Oral Implantol, 2015. 8(2): p. 143-9.
[17]. Genovesi, A., et al., The efficacy of 0.12% chlorhexidine versus 0.12% chlorhexidine plus hyaluronic acid mouthwash on healing of submerged single implant insertion areas: a short-term randomized controlled clinical trial. Int J Dent Hyg, 2017. 15(1): p. 65-72.
[18]. 徐晓明等, 口腔专业护理对糖尿病患者种植体周围炎干预评价. 现代中西医结合杂志, 2015(9): 第1011-1013页.
[19]. Anner, R., et al., Smoking, diabetes mellitus, periodontitis, and supportive periodontal treatment as factors associated with dental implant survival: a long-term retrospective evaluation of patients followed for up to 10 years. 2010. 19(1): p. 57-64.
[20]. Ghiraldini, B., et al., Influence of Glycemic Control on Peri-Implant Bone Healing: 12-Month Outcomes of Local Release of Bone-Related Factors and Implant Stabilization in Type 2 Diabetics. Clin Implant Dent Relat Res, 2016. 18(4): p. 801-9.
[21]. Thomas, D.M., et al., Insulin receptor expression in primary and cultured osteoclast-like cells. Bone, 1998. 23(3): p. 181-6.
[22]. Vestergaard, P., Bone metabolism in type 2 diabetes and role of thiazolidinediones. Curr Opin Endocrinol Diabetes Obes, 2009. 16(2): p. 125-31.
[23]. Conover, C.A., et al., Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology, 1996. 137(8): p. 3295-301.
[24]. McCracken, M.S., et al., Bone associated with implants in diabetic and insulin-treated rats. Clin Oral Implants Res, 2006. 17(5): p. 495-500.
[25]. Zou, G.K., et al., Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. Oral Surgery Oral Medicine Oral Pathology & Oral Radiology, 2012. 114(3): p. 284-289.
[26]. Wang, F., et al., Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol, 2010. 640(1-3): p. 226-32.
[27]. Kanazawa, I., T. Yamaguchi and T. Sugimoto, Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus. Metabolism-clinical & Experimental, 2010. 59(9): p. 1252-1256.
[28]. Luo, E., et al., Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomater, 2012. 8(2): p. 734-43.
[29]. Claustrat, B., J. Brun and G. Chazot, The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews, 2005. 9(1): p. 11-24.
[30]. Yildirimturk, S., et al., The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats. J Appl Oral Sci, 2016. 24(3): p. 239-49.
[31]. Guo, T., et al., Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Diabetes, 2012. 61(10): p. 2414-23.
[32]. Wallner, C., et al., Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2. Scientific Reports, 2017. 7(1).
[33]. Yeo, I.S., Reality of Dental Implant Surface Modification: A Short Literature Review. Open Biomedical Engineering Journal, 2014. 8(8): p. 114-119.
[34]. Li, X., et al., Osseointegration of chitosan coated porous titanium alloy implant by reactive oxygen species-mediated activation of the PI3K/AKT pathway under diabetic conditions. Biomaterials, 2015. 36: p. 44-54.
[35]. Arai, Y., T. Miyayama and S. Hirano, Difference in the toxicity mechanism between ion and nanoparticle forms of silver in the mouse lung and in macrophages. Toxicology, 2015. 328(xxx): p. 84-92.
[36]. Qin, H., et al., Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int J Nanomedicine, 2014. 2014(Issue 1): p. 2469-2478.
[37]. Qin, H., et al., Antimicrobial and Osteogenic Properties of Silver Ion Implanted Stainless Steel. Acs Appl Mater Interfaces, 2015. 7(20): p. 10785-10794.
[38]. Zhong, X., et al., Titanium Surface Priming with Phase-Transited Lysozyme to Establish a Silver Nanoparticle-Loaded Chitosan/Hyaluronic Acid Antibacterial Multilayer via Layer-by-Layer Self-Assembly. Plos One, 2016. 11(1): p. e0146957.
[39]. Richardson, J.J., M. Bj?rnmalm and F. Caruso, Multilayer assembly. Technology-driven layer-by-layer assembly of nanofilms. Science, 2015. 348(6233): p. aaa2491.
[40]. 吴霞等, 大鼠下颌骨来源的成骨细胞对甲硝唑和替硝唑的转运. 口腔颌面修复学杂志, 2007. 8(1): 第59-62页.
[41]. Sykaras, N., et al., Osseointegration of dental implants complexed with rhBMP-2: a comparative histomorphometric and radiographic evaluation. Int J Oral Maxillofac Implants, 2004. 19(5): p. 667-678.
[42]. 刘洪臣, 人工种植体全身给药装置, 2007, CN.
[43]. 张爽, 周毅与王贻宁. 牙种植体载药基台的设计制作及体外抑菌效果初探. in 第八次全国口腔修复学学术年会论文汇编. 2014.
[44]. SMaxwell, C. and R. JWood, Update on vitamin D and type 2 diabetes. Nutrition Reviews, 2011. 69(5): p. 291-295.
[45]. Xiong, Y., et al., 1α,25-Dihydroxyvitamin D3 increases implant osseointegration in diabetic mice partly through FoxO1 inactivation in osteoblasts. Biochem Biophys Res Commun, 2017. 6(3): p. 320-324.
[46]. Dong, L. and C. Wang, Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering. Trends in Biotechnology, 2013. 31(6): p. 342-346.
[47]. Z, H., et al., Immunomodulatory ECM-like Microspheres for Accelerated Bone Regeneration in Diabetes Mellitus. Acs Appl Mater Interfaces, 2018. 10(3).